HARROW, INC. — Director's Dealing 2016

Apr 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2016-04-25

Reporting Person: BOLL ANDREW R. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-25	Executive RSU	$0	A	157500	Acquired	2021-04-25	Common Stock (157500)	Direct
2016-04-25	Executive RSU	$0	D	157500	Disposed	2016-04-25	Common Stock (157500)	Direct

Footnotes

F1: Represents performance-based restricted stock units (the "RSUs") granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan"). The RSUs settle in one share of common stock for each RSU on the fifth anniversary of the grant date and provide for accelerated vesting based on pre-determined stock-price based performance targets during the term of the RSUs.

F2: Represents RSUs granted under the Plan to Mr. Boll on February 1, 2015, which were forfeited by Mr. Boll on April 25, 2016, with the approval of the board of directors of the Issuer, upon issuance of the new RSUs indicated in footnote 1.